Literature DB >> 19038971

Phosphoinositide 3-kinase signalling in the vascular system.

Fulvio Morello1, Alessia Perino, Emilio Hirsch.   

Abstract

Phosphoinositide 3-kinases (PI3Ks) are protein and lipid kinases activated by different classes of membrane receptors, including G-protein coupled and tyrosine kinase receptors. Several lines of evidence have uncovered specific roles for distinct PI3K isoforms in the vascular system in both physiology and disease. The present review will summarize and discuss the most recent advances regarding PI3K-Akt signalling in endothelial cells, vascular smooth muscle cells, platelets, and inflammatory cells involved in the atherosclerotic process. Of interest, the development of novel isoform-selective PI3K inhibitor drugs offers a unique opportunity to selectively and differentially target PI3K-driven pathways in the vascular system and may give rise to new strategies for the treatment of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038971     DOI: 10.1093/cvr/cvn325

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  72 in total

1.  Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelin(A) receptor-operated native TRPC channels in rabbit coronary artery myocytes.

Authors:  J Shi; M Ju; W A Large; A P Albert
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells.

Authors:  Pasithorn A Suwanabol; Stephen M Seedial; Fan Zhang; Xudong Shi; Yi Si; Bo Liu; K Craig Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

3.  TGF-β1 induces human aortic vascular smooth muscle cell phenotype switch through PI3K/AKT/ID2 signaling.

Authors:  Shui-Bo Zhu; Jian Zhu; Zi-Zi Zhou; Er-Ping Xi; Rong-Ping Wang; Yu Zhang
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

4.  Role of PTEN in modulation of ADP-dependent signaling pathways in vascular endothelial cells.

Authors:  Rosa Bretón-Romero; Hermann Kalwa; Santiago Lamas; Thomas Michel
Journal:  Biochim Biophys Acta       Date:  2013-06-25

5.  Differential phosphoinositide 3-kinase signaling: implications for PTCA?

Authors:  Petra Rocic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-16       Impact factor: 4.733

6.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

Authors:  Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman
Journal:  Blood       Date:  2014-04-22       Impact factor: 22.113

Review 7.  MicroRNA control of vascular endothelial growth factor signaling output during vascular development.

Authors:  Lan T H Dang; Nathan D Lawson; Jason E Fish
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

8.  P110α and P110δ catalytic subunits of PI3 kinase regulate lysophosphatidylcholine-induced TRPC6 externalization.

Authors:  Pinaki Chaudhuri; Andrew H Smith; Priya Putta; Linda M Graham; Michael A Rosenbaum
Journal:  Am J Physiol Cell Physiol       Date:  2021-02-24       Impact factor: 4.249

9.  Exogenous spermine inhibits hypoxia/ischemia-induced myocardial apoptosis via regulation of mitochondrial permeability transition pore and associated pathways.

Authors:  Can Wei; Hongzhu Li; Yuehong Wang; Xue Peng; Hongjiang Shao; Hongxia Li; Shuzhi Bai; Changqing Xu
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-25

10.  Inhibition of Gαi activity by Gβγ is mediated by PI 3-kinase-γ- and cSrc-dependent tyrosine phosphorylation of Gαi and recruitment of RGS12.

Authors:  Jiean Huang; Ancy D Nalli; Sunila Mahavadi; Divya P Kumar; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-02-27       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.